Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Ophthalmology. 2015 May 20;122(8):1669–1674. doi: 10.1016/j.ophtha.2015.04.011

Table 1.

Characteristics of the study population

Characteristic
Age mean ± SD years 56 ± 12
Gender (%)
 Male 56 (67)
 Female 28 (33)
Primary Disorder (%)
 Acute myeloid leukemia 33 (39)
 Acute lymphoid leukemia 6 (7)
 Chronic myeloid leukemia 5 (6)
 Chronic lymphoid leukemia 10 (12)
 Myelodysplastic syndrome 11 (13)
 Non-Hodgkin Lymphoma 13 (16)
 Hodgkin Lymphoma 1 (1)
 Multiple myeloma 3 (4)
 Others 2 (2)
Duration since HSCT in days mean ± SD 1348 ± 1002
Duration since diagnosis of ocular GVHD in days mean ± SD 873 ± 955

SD: standard deviation; HSCT: hematopoietic stem cell transplantation; GVHD: graft-versus-host disease.